Aaron D. Showalter
Impact in
-
- Diabetes Treatment and Management
- Growth Hormone and Insulin-like Growth Factors
-
- Neuropeptides and Animal Physiology
Papers in
-
- Receptor Mechanisms and Signaling 13
- Congenital heart defects research 3
-
- Diabetes Treatment and Management 14
- Growth Hormone and Insulin-like Growth Factors 6
- Co-authors
- Kyle W. Sloop (25 shared papers)Francis S. Willard (13 shared papers)Simon J. Rhodes (9 shared papers)David B. Wainscott (7 shared papers)James Ficorilli (7 shared papers)Cynthia Stutsman (5 shared papers)Matthew P. Coghlan (3 shared papers)Barbara Kluve‐Beckerman (2 shared papers)
- Journals
- Diabetes (4 papers)Gene (3 papers)Molecular Pharmacology (2 papers)Annals of Medicine (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Aaron D. Showalter
28 papers receiving 1.3k citations
Aaron D. Showalter's Hit Papers
Peers
Comparison fields: 5 of 82
- Endocrinology, Diabetes and Metabolism 718
- Cellular and Molecular Neuroscience 278
- Molecular Biology 772
- Pharmacology 135
- Surgery 277
Countries citing papers authored by Aaron D. Showalter
This map shows the geographic impact of Aaron D. Showalter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron D. Showalter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron D. Showalter more than expected).
Fields of papers citing papers by Aaron D. Showalter
This network shows the impact of papers produced by Aaron D. Showalter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron D. Showalter. The network helps show where Aaron D. Showalter may publish in the future.
Co-authors
The 25 scholars most cited alongside Aaron D. Showalter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist Hit paper breakdown → | 2020 | 340 |
| 2 | 2020 | 132 | |
| 3 | 2010 | 122 | |
| 4 | 2006 | 110 | |
| 5 | 2020 | 71 | |
| 6 | 2012 | 61 | |
| 7 | 2014 | 54 | |
| 8 | 2016 | 50 | |
| 9 | 2014 | 49 | |
| 10 | 2012 | 44 | |
| 11 | 2000 | 39 | |
| 12 | 2002 | 37 | |
| 13 | 2010 | 34 | |
| 14 | 2013 | 32 | |
| 15 | 2000 | 30 | |
| 16 | 2014 | 25 | |
| 17 | 2002 | 22 | |
| 18 | 2010 | 18 | |
| 19 | 2021 | 14 | |
| 20 | 2001 | 13 |
About Aaron D. Showalter
Aaron D. Showalter is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Surgery, Genetics and Cellular and Molecular Neuroscience, having authored 28 papers that have together received 1.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (14 papers), Receptor Mechanisms and Signaling (13 papers), Pancreatic function and diabetes (8 papers), Growth Hormone and Insulin-like Growth Factors (6 papers), Genetic Syndromes and Imprinting (4 papers), Neuropeptides and Animal Physiology (4 papers), Congenital heart defects research (3 papers) and Animal Genetics and Reproduction (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (718 citations), Cellular and Molecular Neuroscience (278 citations), Molecular Biology (772 citations), Pharmacology (135 citations) and Surgery (277 citations). Aaron D. Showalter has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Kyle W. Sloop, Francis S. Willard, Simon J. Rhodes, David B. Wainscott, James Ficorilli, Cynthia Stutsman, Matthew P. Coghlan, Barbara Kluve‐Beckerman, Merrill D. Benson and Guemalli R. Cardona. Their work appears in journals such as Diabetes, Gene, Molecular Pharmacology, Annals of Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.